Recent Advances in the Pathogenesis and Treatment of Kidney Diseases. Группа авторов

minimal-change nephrotic syndrome in adults. Nephrol Dial Transplant 2013;28:1225–1232.

17Iwabuchi Y, Takei T, Moriyama T, et al: Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine (Baltimore) 2014;93:e300.

18Miyabe Y, Takei T, Iwabuchi Y, et al: Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome. Clin Exp Nephrol 2016;20:103–110.

19Kimata T, Hasui M, Kino J, Kitao T, Yamanouchi S, Tsuji S, Kaneko K: Novel use of rituximab for steroid-dependent nephrotic syndrome in children. Am J Nephrol 2013;38:483–488.

20Ito S, Kamei K, Ogura M, et al: Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2011;26:1823–1828.

21Takura T, Takei T, Nitta K: Cost-effectiveness of administering rituximab for steroid-dependent nephrotic syndrome and frequently relapsing nephrotic syndrome: a preliminary study in Japan. Sci Rep 2017;7:46036.

      Kosaku Nitta, MD, PhD

      Department of Medicine, Kidney Center

      Tokyo Women’s Medical University

      8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666 (Japan)

      E-Mail [email protected]